1887

Abstract

Adult T-cell leukaemia/lymphoma (ATL) is a highly aggressive CD4 T-cell malignancy caused by human T-cell leukaemia virus type 1. Measles virus (MV) oncolytic therapy has been reported to be efficient in reducing tumour burden in subcutaneous xenograft models of lymphoproliferative disorders such as myeloma, B-cell lymphoma and cutaneous T-cell lymphoma, but its potential to reduce tumour burden in disseminated lymphoproliferative disorders such as ATL remains to be determined. In this study, MV oncolytic therapy was evaluated in the MET-1/NOD/SCID xenograft mouse model of ATL. Treatment with the vaccine-related strain MV-NSE led to a significant reduction in tumour burden. In mice with a high tumour burden, therapy with MV-NSE significantly increased survival beyond any other single treatment tested previously using this model. Interestingly, signs of morbidity (cachexia) in mice treated with MV were not directly associated with tumour burden, but were correlated with the secretion of interleukin-6 by MET-1 cells and host cells. The results suggest that MV therapy could be a promising therapy for generalized lymphoproliferative disease.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.028910-0
2011-06-01
2020-01-21
Loading full text...

Full text loading...

/deliver/fulltext/jgv/92/6/1458.html?itemId=/content/journal/jgv/10.1099/vir.0.028910-0&mimeType=html&fmt=ahah

References

  1. Argilés J. M., López-Soriano F. J.. ( 1999;). The role of cytokines in cancer cachexia. . Med Res Rev 19:, 223–248. [CrossRef][PubMed]
    [Google Scholar]
  2. Barton B. E., Murphy T. F.. ( 2001;). Cancer cachexia is mediated in part by the induction of IL-6-like cytokines from the spleen. . Cytokine 16:, 251–257. [CrossRef][PubMed]
    [Google Scholar]
  3. Chen J., Zhang M., Ju W., Waldmann T. A.. ( 2009;). Effective treatment of a murine model of adult T-cell leukemia using depsipeptide and its combination with unmodified daclizumab directed toward CD25. . Blood 113:, 1287–1293. [CrossRef][PubMed]
    [Google Scholar]
  4. Couturier M., Buccellato M., Costanzo S., Bourhis J. M., Shu Y., Nicaise M., Desmadril M., Flaudrops C., Longhi S. et al. ( 2009;). High affinity binding between Hsp70 and the C-terminal domain of the measles virus nucleoprotein requires an Hsp40 co-chaperone. . J Mol Recognit 23:, 301–315.
    [Google Scholar]
  5. Evans S. S., Collea R. P., Appenheimer M. M., Gollnick S. O.. ( 1993;). Interferon-α induces the expression of the L-selectin homing receptor in human B lymphoid cells. . J Cell Biol 123:, 1889–1898. [CrossRef][PubMed]
    [Google Scholar]
  6. Grote D., Russell S. J., Cornu T. I., Cattaneo R., Vile R., Poland G. A., Fielding A. K.. ( 2001;). Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice. . Blood 97:, 3746–3754. [CrossRef][PubMed]
    [Google Scholar]
  7. Heinzerling L., Künzi V., Oberholzer P. A., Kündig T., Naim H., Dummer R.. ( 2005;). Oncolytic measles virus in cutaneous T-cell lymphomas mounts antitumor immune responses in vivo and targets interferon-resistant tumor cells. . Blood 106:, 2287–2294. [CrossRef][PubMed]
    [Google Scholar]
  8. Künzi V., Oberholzer P. A., Heinzerling L., Dummer R., Naim H. Y.. ( 2006;). Recombinant measles virus induces cytolysis of cutaneous T-cell lymphoma in vitro and in vivo. . J Invest Dermatol 126:, 2525–2532. [CrossRef][PubMed]
    [Google Scholar]
  9. Kuroda K., Nakashima J., Kanao K., Kikuchi E., Miyajima A., Horiguchi Y., Nakagawa K., Oya M., Ohigashi T., Murai M.. ( 2007;). Interleukin 6 is associated with cachexia in patients with prostate cancer. . Urology 69:, 113–117. [CrossRef][PubMed]
    [Google Scholar]
  10. Li M., Green P. L.. ( 2007;). Detection and quantitation of HTLV-1 and HTLV-2 mRNA species by real-time RT-PCR. . J Virol Methods 142:, 159–168. [CrossRef][PubMed]
    [Google Scholar]
  11. Parrula C., Zimmerman B., Nadella P., Shu S., Rosol T., Fernandez S., Lairmore M., Niewiesk S.. ( 2009;). Expression of tumor invasion factors determines systemic engraftment and induction of humoral hypercalcemia in a mouse model of adult T-cell leukemia. . Vet Pathol 46:, 1003–1014. [CrossRef][PubMed]
    [Google Scholar]
  12. Peng K. W., Ahmann G. J., Pham L., Greipp P. R., Cattaneo R., Russell S. J.. ( 2001;). Systemic therapy of myeloma xenografts by an attenuated measles virus. . Blood 98:, 2002–2007. [CrossRef][PubMed]
    [Google Scholar]
  13. Phillips K. E., Herring B., Wilson L. A., Rickford M. S., Zhang M., Goldman C. K., Tso J. Y., Waldmann T. A.. ( 2000;). IL-2Rα-directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Rα interaction. . Cancer Res 60:, 6977–6984.[PubMed]
    [Google Scholar]
  14. Plumet S., Gerlier D.. ( 2005;). Optimized SYBR green real-time PCR assay to quantify the absolute copy number of measles virus RNAs using gene specific primers. . J Virol Methods 128:, 79–87. [CrossRef][PubMed]
    [Google Scholar]
  15. Radecke F., Spielhofer P., Schneider H., Kaelin K., Huber M., Dötsch C., Christiansen G., Billeter M. A.. ( 1995;). Rescue of measles viruses from cloned DNA. . EMBO J 14:, 5773–5784.[PubMed]
    [Google Scholar]
  16. Reed L. J., Muench H.. ( 1938;). A simple method of estimating fifty per cent endpoints. . Am J Hyg 27:, 493–497.
    [Google Scholar]
  17. Segal B. H., Wang X. Y., Dennis C. G., Youn R., Repasky E. A., Manjili M. H., Subjeck J. R.. ( 2006;). Heat shock proteins as vaccine adjuvants in infections and cancer. . Drug Discov Today 11:, 534–540. [CrossRef][PubMed]
    [Google Scholar]
  18. Shultz L. D., Schweitzer P. A., Christianson S. W., Gott B., Schweitzer I. B., Tennent B., McKenna S., Mobraaten L., Rajan T. V. et al. ( 1995;). Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. . J Immunol 154:, 180–191.[PubMed]
    [Google Scholar]
  19. Shultz L. D., Banuelos S. J., Leif J., Appel M. C., Cunningham M., Ballen K., Burzenski L., Greiner D. L.. ( 2003;). Regulation of human short-term repopulating cell (STRC) engraftment in NOD/SCID mice by host CD122+ cells. . Exp Hematol 31:, 551–558. [CrossRef][PubMed]
    [Google Scholar]
  20. Singh M., Billeter M. A.. ( 1999;). A recombinant measles virus expressing biologically active human interleukin-12. . J Gen Virol 80:, 101–106.[PubMed]
    [Google Scholar]
  21. Taglia L., Matusiak D., Benya R. V.. ( 2008;). GRP-induced up-regulation of Hsp72 promotes CD16+/94+ natural killer cell binding to colon cancer cells causing tumor cell cytolysis. . Clin Exp Metastasis 25:, 451–463. [CrossRef][PubMed]
    [Google Scholar]
  22. Vasconcelos D. Y., Cai X. H., Oglesbee M. J.. ( 1998;). Constitutive overexpression of the major inducible 70 kDa heat shock protein mediates large plaque formation by measles virus. . J Gen Virol 79:, 2239–2247.[PubMed]
    [Google Scholar]
  23. Weiss A., Wiskocil R. L., Stobo J. D.. ( 1984;). The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level. . J Immunol 133:, 123–128.[PubMed]
    [Google Scholar]
  24. Yamamoto N., Okada M., Koyanagi Y., Kannagi M., Hinuma Y.. ( 1982;). Transformation of human leukocytes by cocultivation with an adult T cell leukemia virus producer cell line. . Science 217:, 737–739. [CrossRef][PubMed]
    [Google Scholar]
  25. Zhang M., Yao Z., Garmestani K., Axworthy D. B., Zhang Z., Mallett R. W., Theodore L. J., Goldman C. K., Brechbiel M. W. et al. ( 2002;a). Pretargeting radioimmunotherapy of a murine model of adult T-cell leukemia with the α-emitting radionuclide, bismuth 213. . Blood 100:, 208–216. [CrossRef][PubMed]
    [Google Scholar]
  26. Zhang X., Glendening C., Linke H., Parks C. L., Brooks C., Udem S. A., Oglesbee M.. ( 2002;b). Identification and characterization of a regulatory domain on the carboxyl terminus of the measles virus nucleocapsid protein. . J Virol 76:, 8737–8746. [CrossRef][PubMed]
    [Google Scholar]
  27. Zhang M., Zhang Z., Garmestani K., Schultz J., Axworthy D. B., Goldman C. K., Brechbiel M. W., Carrasquillo J. A., Waldmann T. A.. ( 2003;a). Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xenografts. . Proc Natl Acad Sci U S A 100:, 1891–1895. [CrossRef][PubMed]
    [Google Scholar]
  28. Zhang Z., Zhang M., Ravetch J. V., Goldman C., Waldmann T. A.. ( 2003;b). Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD2 monoclonal antibody, MEDI-507. . Blood 102:, 284–288. [CrossRef][PubMed]
    [Google Scholar]
  29. Zhang M., Zhang Z., Goldman C. K., Janik J., Waldmann T. A.. ( 2005;). Combination therapy for adult T-cell leukemia-xenografted mice: flavopiridol and anti-CD25 monoclonal antibody. . Blood 105:, 1231–1236. [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.028910-0
Loading
/content/journal/jgv/10.1099/vir.0.028910-0
Loading

Data & Media loading...

Most cited articles

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error